Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Acne and hair loss in women can greatly lower their quality of life, but having polycystic ovarian syndrome does not.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Chinese domestic goats have unique genetic traits due to domestication and geographic isolation.

Facelifts for Asians are challenging due to thicker, heavier skin.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

The document explains breast development, common breast conditions, and their treatments.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

More research is needed to understand how testosterone is maintained in adult males.

A 15-year-old girl has a skin condition causing blisters on her feet, likely inherited from her family.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

American men are older, more obese, and have longer infertility than Canadian men.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.